We hypothesize that PTEN may play the inhibitory roles by targeting survivin, and that survivin can only be reduced by the PTEN/PI3K/AKT pathway in RA-FLS cell proliferation. This evidence concerns the gene BIRC5 and rheumatoid arthritis.